There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vera Therapeutics (VERA – Research Report), ...

Shares of Vera Therapeutics stock opened at $29.93 on Thursday. The stock has a market capitalization of $1.90 billion, a P/E ratio of -11.47 and a beta of 1.11. The company has a quick ratio of ...

Vera stock dropped after Otsuka announced plans for accelerated approval of sibeprenlimab, but analysts believe the selloff was an overreaction. Atacicept is more disease-modifying, while ...

Feb. 26, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for ...

Our round-up of recent biotech financings is headed by a $250 million public offering for late clinical-stage biotech Vera Therapeutics, with an initial public offering (IPO) filed by CAR-T ...

A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Vera Therapeutics Inc (Symbol: VERA) entered into oversold territory, hitting an RSI ...

Investing.com’s Fair Value model demonstrated remarkable accuracy in identifying overvalued stocks, as evidenced by its September 2024 analysis of Vera Therapeutics (NASDAQ:VERA). The model’s ...